PersicogeninCAS# 28590-40-1 |
| Cas No. | 28590-40-1 | SDF | File under preparation. |
| PubChem ID | 320054 | Appearance | Powder |
| Formula | C17H16O6 | M.Wt | 316.30 |
| Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-methoxy-2,3-dihydrochromen-4-one | ||
| SMILES | COC1=C(C=C(C=C1)C2CC(=O)C3=C(C=C(C=C3O2)OC)O)O | ||
| Standard InChIKey | LWBHKKLWSUFUNZ-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C17H16O6/c1-21-10-6-12(19)17-13(20)8-15(23-16(17)7-10)9-3-4-14(22-2)11(18)5-9/h3-7,15,18-19H,8H2,1-2H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Quality Control & MSDS
3D structure
Package In Stock

Number of papers citing our products

| Description | 1. Persicogenin has anticancer activity, it can inhibit the proliferation of mouse tsFT210 cancer cells, it mainly inhibits cell cycle at the G2/M phase in a dose-dependent manner. 2. Persicogenin shows the antimutagenic effect against AFB1. 3. Persicogenin possesses antileishmanial activity. |
| Targets | Antifection |
Persicogenin Dilution Calculator
Persicogenin Molarity Calculator
-
Hesperetin-7-methyl etherCatalog No.: BCN8501CAS No.: -
7,3',4'-Tri-O-methyleriodictyolCatalog No.: BCN7766CAS No.: 70987-96-1 -
HesperetinCatalog No.: BCN5657CAS No.: 520-33-2 -
(Rac)-HesperetinCatalog No.: BCN0325CAS No.: 69097-99-0 -
Eriodictyol 7,3'-dimethyl etherCatalog No.: BCN8105CAS No.: 54352-60-2 -
7-O-MethyleriodictyolCatalog No.: BCN5648CAS No.: 51857-11-5 -
4',7-Di-O-methylnaringeninCatalog No.: BCN5197CAS No.: 29424-96-2 -
SakuranetinCatalog No.: BCN5199CAS No.: 2957-21-3 -
(RS)-SakuranetinCatalog No.: BCN0343CAS No.: 520-29-6 -
PinostrobinCatalog No.: BCN5555CAS No.: 480-37-5 -
BlumeatinCatalog No.: BCN6055CAS No.: 118024-26-3 -
3',5-Dihydroxy-4',6,7-trimethoxyflavanoneCatalog No.: BCN0183CAS No.: 90850-99-0 -
HomoeriodictyolCatalog No.: BCN6804CAS No.: 446-71-9 -
IsosakuranetinCatalog No.: BCN5559CAS No.: 480-43-3 -
Hesperetin 7-O-glucosideCatalog No.: BCN5237CAS No.: 31712-49-9 -
Naringenin trimethyl etherCatalog No.: BCN5437CAS No.: 38302-15-7 -
TsugafolinCatalog No.: BCN4026CAS No.: 66568-97-6 -
PersicosideCatalog No.: BCN4780CAS No.: 28978-03-2 -
Blumeatin BCatalog No.: BCN4335CAS No.: 79995-67-8 -
2,3-Dihydroamentoflavone 7,4'-dimethyl etherCatalog No.: BCN1320CAS No.: 873999-88-3 -
2,3-dihydrosciadopitysinCatalog No.: BCN4034CAS No.: 34421-19-7 -
5,7-Dihydroxy-3',4',5'-trimethoxyflavanoneCatalog No.: BCN0136CAS No.: 62252-10-2 -
EriodictyolCatalog No.: BCN1209CAS No.: 552-58-9 -
(+/-)-EriodictyolCatalog No.: BCN0319CAS No.: 4049-38-1 -
4'-O-MethyllicoflavanoneCatalog No.: BCN4827CAS No.: 1038753-13-7 -
5,7-DimethoxyflavanoneCatalog No.: BCN3569CAS No.: 1036-72-2 -
5-O-MethylnaringeninCatalog No.: BCN4144CAS No.: 61775-19-7 -
(2R)-5,7-DimethoxyflavanoneCatalog No.: BCN7806CAS No.: 1277188-85-8 -
Naringenin-4',7-diacetateCatalog No.: BCN1144CAS No.: 18196-13-9 -
HesperidinCatalog No.: BCN5654CAS No.: 520-26-3
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.1616 mL | 15.8078 mL | 31.6156 mL | 63.2311 mL | 79.0389 mL |
| 5 mM | 0.6323 mL | 3.1616 mL | 6.3231 mL | 12.6462 mL | 15.8078 mL |
| 10 mM | 0.3162 mL | 1.5808 mL | 3.1616 mL | 6.3231 mL | 7.9039 mL |
| 50 mM | 0.0632 mL | 0.3162 mL | 0.6323 mL | 1.2646 mL | 1.5808 mL |
| 100 mM | 0.0316 mL | 0.1581 mL | 0.3162 mL | 0.6323 mL | 0.7904 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
- 7-Geranyloxy-6-methoxycoumarin
Catalog No.:BCN5181
CAS No.:28587-43-1
- 4-Benzoyloxy-2-azetidinone
Catalog No.:BCC8696
CAS No.:28562-58-5
- Theaflavin-3'-gallate
Catalog No.:BCN5421
CAS No.:28543-07-9
- BML-190
Catalog No.:BCC4410
CAS No.:2854-32-2
- 1-Amino-2-methylpropan-2-ol
Catalog No.:BCN1773
CAS No.:2854-16-2
- Anadoline N-oxide
Catalog No.:BCN2029
CAS No.:28513-29-3
- Malvidin-3-O-arabinoside chloride
Catalog No.:BCN3032
CAS No.:28500-04-1
- Petunidin-3-O-arabinoside chloride
Catalog No.:BCN3026
CAS No.:28500-03-0
- Petunidin-3-O-galactoside chloride
Catalog No.:BCN3024
CAS No.:28500-02-9
- Delphinidin-3-O-galactoside chloride
Catalog No.:BCN3019
CAS No.:28500-00-7
- 9-Deacetyltaxinine E
Catalog No.:BCN7227
CAS No.:284672-78-2
- 20-Deacetyltaxuspine X
Catalog No.:BCN7374
CAS No.:284672-76-0
- Eicosanyl caffeate
Catalog No.:BCN7209
CAS No.:28593-90-0
- Docosyl caffeate
Catalog No.:BCN5182
CAS No.:28593-92-2
- 22-Dehydroclerosteryl acetate
Catalog No.:BCN5183
CAS No.:28594-00-5
- BIRB 796 (Doramapimod)
Catalog No.:BCC2535
CAS No.:285983-48-4
- CCG-1423
Catalog No.:BCC5581
CAS No.:285986-88-1
- Orientin
Catalog No.:BCN4984
CAS No.:28608-75-5
- Isoanhydroicaritin
Catalog No.:BCN3879
CAS No.:28610-30-2
- 8-Prenylkaempferol
Catalog No.:BCN3311
CAS No.:28610-31-3
- Erythristemine
Catalog No.:BCN5184
CAS No.:28619-41-2
- S 14506 hydrochloride
Catalog No.:BCC7174
CAS No.:286369-38-8
- KRN 633
Catalog No.:BCC2544
CAS No.:286370-15-8
- Nigericin sodium salt
Catalog No.:BCC7915
CAS No.:28643-80-3
Antimycobacterial activity and cytotoxicity of flavonoids from the flowers of Chromolaena odorata.[Pubmed:15202555]
Arch Pharm Res. 2004 May;27(5):507-11.
From the flowers of Chromolaena odorata (Eupatorium odoratum) four flavanones, isosakuranetin (5,7-dihydroxy-4'-methoxyflavanone) (1), Persicogenin (5,3'-dihydroxy-7,4'-dimethoxyflavanone) (2), 5,6,7,4'-tetramethoxyflavanone (3) and 4'-hydroxy-5,6,7-trimethoxyflavanone (4), two chalcones, 2'-hydroxy-4,4',5',6'-tetramethoxychalcone (5) and 4,2'-dihydroxy-4',5',6'-trimethoxychalcone (6), and two flavones, acacetin (5,7-dihydroxy-4'-methoxyflavone) (7) and luteolin (5,7,3',4'-tetrahydroxyflavone) (8) were isolated and identified. Compound 1 exhibited moderate antimycobacterial activity against Mycobacterium tuberculosis with the MIC value of 174.8 microM, whereas compounds 4, 7, and 8 exhibited weak activity with the MIC values of 606.0, 704.2 and 699.3 microM respectively. Compound 7 showed moderate cytotoxicity against human small cell lung cancer (NCI-H187) cells with the MIC value of 24.6 microM, whereas compound 8 exhibited moderate toxicity against NCI-H187 cells and week toxicity against human breast cancer (BC) cells with the MIC values of 19.2 and 38.4 microM respectively.
Antimutagenic effect of plant flavonoids in the Salmonella assay system.[Pubmed:10319134]
Arch Pharm Res. 1994 Apr;17(2):71-5.
The antimutagenic effects of 27 kinds of plant flavonoids on the mutagenicity of aflatoxin B1(AFB1) and N-methyl-N'-nitro-N-nitrosoguanidine(MNNG) in Salmonella typhimurium TA100 were investigated. In the mixed applications of AFB1 (1 microgram/plate) with the flavonoids (300 micrograms/plate) in the presence of a mammalian metabolic activation system (S9 mix), chrysin, apigenin, luteolin and its glucoside, kaempferol, fisetin, morin, naringenin, hesperetin, Persicogenin, (+)-catechin and (-)-epicatechin showed the antimutagenic effect against AFB1 with more than 70% inhibition rate. A little or no antimutagenicities except flavone against MNNG (0.5 microgram/plate) were observed. For the antimutagenicity of the flavonoids on AFB1, the flavonoid structure that contains the free 5-, 7-hydroxyl group seemed to be essential. However, saturation of the 2,3-double bond or elimination of the 4-keto group did not affect the activity.
Flavonoids from Vitex trifolia L. inhibit cell cycle progression at G2/M phase and induce apoptosis in mammalian cancer cells.[Pubmed:16087636]
J Asian Nat Prod Res. 2005 Aug;7(4):615-26.
Six flavonoids, Persicogenin (1), artemetin (2), luteolin (3), penduletin (4), vitexicarpin (5) and chrysosplenol-D (6), have been isolated for the first time as new cell cycle inhibitors from Vitex trifolia L., a Chinese folk medicine used to treat cancers, through a bioassay-guided separation procedure. They were identified by spectroscopic methods. The inhibitory effects of 1-6 on the proliferation of mammalian cancer cells have been evaluated by the SRB (sulforhodamine B) method and their effects on cell cycle and apoptosis investigated by flow cytometry with the morphological observation under light microscope and by agarose-gel electrophoresis to detect internucleosomal DNA fragmentation. Compounds 1-6 inhibited the proliferation of mouse tsFT210 cancer cells with the IC50s (microg ml(-1)) > 100 (inhibition rate at 100 microg ml(-1), 47.9%) for 1, >100 (inhibition rate at 100 microg ml(-1), 49.6 %) for 2, 10.7 for 3, 19.8 for 4, 0.3 for 5, and 3.5 for 6. Flow cytometric investigations for 1-6 demonstrated that 1-5 mainly inhibited cell cycle at the G2/M phase in a dose-dependent manner with a weak induction of apoptosis on the tsFT210 cells, while 6 induced mainly apoptosis of the same tsFT210 cells also in a dose-dependent manner together with a weak inhibition of the cell cycle at the G0/G1 and G2/M phases, demonstrating that 1-6 exert their anti-proliferative effect on tsFT210 cells through inhibiting cell cycle and inducing apoptosis. In contrast to the cell cycle G2/M phase inhibitory main effect on tsFT210 cells, 5 induced mainly apoptosis on human myeloid leukemia K562 cells with a weak inhibition of the cell cycle at the G2/M phase. The present result provides flavonoids 1-6 as new cell cycle inhibitors and 1 and 4 as new anticancer flavonoids, which not only provide the first example of cell cycle G2/M phase inhibitory and apoptosis-inducing constituents of V. trifolia L. but also explain the use of Vitex trifolia L. by Chinese people to treat cancers.
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University


